Primus In News
Indian CDMOs get a growth pill
28-01-2026
Nilaya Varma, Group CEO and Co-Founder, Primus Partners, shared his view that the free trade agreement would open access to Europe’s pharmaceutical and medical devices market, valued at around $572 billion, while strengthening India’s position as a global manufacturing hub.
Explore Related Insights
- Budget 2024 Expectations: Income tax rebate to home loan tax exemption. What ‘aam aadmi’ expects from FM Sitharaman
- Eye on 9 million plus EV sales by 2027, government, auto companies gear up to tap India’s potential
- Tamil Nadu will soon come out with a AVGC-XR policy
- Bessemer chases AI startup that could disrupt India’s IT Sector
